國立虎尾科技大學 |

Management of Bladder Cancer = A Comprehensive Text With Clinical Scenarios /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Management of Bladder Cancer/ edited by Badrinath R. Konety, Sam S. Chang.
其他題名:	A Comprehensive Text With Clinical Scenarios /
其他作者:	Konety, Badrinath R.
面頁冊數:	XX, 479 p. 74 illus., 68 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology. -
電子資源:	https://doi.org/10.1007/978-1-4939-1881-2
ISBN:	9781493918812

Management of Bladder Cancer = A Comprehensive Text With Clinical Scenarios /
Management of Bladder CancerA Comprehensive Text With Clinical Scenarios /[electronic resource] :edited by Badrinath R. Konety, Sam S. Chang. - 1st ed. 2015. - XX, 479 p. 74 illus., 68 illus. in color.online resource.

Epidemiology and natural history -- Screening for Bladder Cancer -- Pathology and Staging: Histopathology and Cytopathology -- Pathology and Staging: Genetics and Molecular Biology -- Imaging in Localized and Advanced Bladder Cancer -- New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder -- Socioeconomic issues and improved quality of care -- Quality of life measures -- Prognostication and risk assessment -- Clinical trials and emerging therapeutic strategies in bladder cancer -- Improved diagnostic techniques -- Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging -- Localized surgical therapy and surveillance -- Clinical Scenario: Initial high grade Ta tumor -- Clinical Scenario: Recurrent Ta tumor -- Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor -- Clinical Scenario: Low grade T1 tumor -- Intravesical therapy -- Clinical Scenario: Initial CIS -- Management of BCG Recurrent Bladder Cancer -- Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG -- Maurizio Brausi -- Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation -- Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines -- Open Radical Cystectomy -- Robotic cystectomy -- Clinical Scenario: T2 bladder tumor -- Urinary Diversion: Open and robotic techniques -- Chemoradiotherapy -- Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation -- Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application -- Clinical Scenario: Large volume, non metastatic T2 bladder tumor -- The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer -- Clinical Scenario: Unexpected positive nodes at radical cystectomy -- Surveillance and monitoring -- Clinical Scenario: The Role of Perioperative Chemotherapy -- Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy -- Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU.

This book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinical research are highlighted. Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.

ISBN: 9781493918812

Standard No.: 10.1007/978-1-4939-1881-2doiSubjects--Topical Terms:

593951
Oncology.

LC Class. No.: RC870-923.2

Dewey Class. No.: 616.6

Management of Bladder Cancer = A Comprehensive Text With Clinical Scenarios /
LDR:04979nam a22004095i 4500 001 968451
003 DE-He213
005 20200707022024.0
007 cr nn 008mamaa
008 201211s2015 xxu| s |||| 0|eng d
020 $a 9781493918812 $9 978-1-4939-1881-2
024 7 $a 10.1007/978-1-4939-1881-2 $2 doi
035 $a 978-1-4939-1881-2
050 4 $a RC870-923.2
050 4 $a RC875-899.5
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
072 7 $a MJS $2 thema
082 0 4 $a 616.6 $2 23
245 1 0 $a Management of Bladder Cancer $h [electronic resource] : $b A Comprehensive Text With Clinical Scenarios / $c edited by Badrinath R. Konety, Sam S. Chang.
250 $a 1st ed. 2015.
264 1 $a New York, NY : $b Springer New York : $b Imprint: Springer, $c 2015.
300 $a XX, 479 p. 74 illus., 68 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Epidemiology and natural history -- Screening for Bladder Cancer -- Pathology and Staging: Histopathology and Cytopathology -- Pathology and Staging: Genetics and Molecular Biology -- Imaging in Localized and Advanced Bladder Cancer -- New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder -- Socioeconomic issues and improved quality of care -- Quality of life measures -- Prognostication and risk assessment -- Clinical trials and emerging therapeutic strategies in bladder cancer -- Improved diagnostic techniques -- Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging -- Localized surgical therapy and surveillance -- Clinical Scenario: Initial high grade Ta tumor -- Clinical Scenario: Recurrent Ta tumor -- Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor -- Clinical Scenario: Low grade T1 tumor -- Intravesical therapy -- Clinical Scenario: Initial CIS -- Management of BCG Recurrent Bladder Cancer -- Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG -- Maurizio Brausi -- Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation -- Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines -- Open Radical Cystectomy -- Robotic cystectomy -- Clinical Scenario: T2 bladder tumor -- Urinary Diversion: Open and robotic techniques -- Chemoradiotherapy -- Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation -- Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application -- Clinical Scenario: Large volume, non metastatic T2 bladder tumor -- The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer -- Clinical Scenario: Unexpected positive nodes at radical cystectomy -- Surveillance and monitoring -- Clinical Scenario: The Role of Perioperative Chemotherapy -- Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy -- Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU.
520 $a This book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinical research are highlighted. Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.
650 2 4 $a Oncology. $3 593951
650 0 $a Urology. $3 645258
650 0 $a Oncology . $3 1253469
650 0 $a Interventional radiology . $3 1254011
650 2 4 $a Interventional Radiology. $3 673687
700 1 $a Konety, Badrinath R. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064534
700 1 $a Chang, Sam S. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064535
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9781493918805
776 0 8 $i Printed edition: $z 9781493918829
776 0 8 $i Printed edition: $z 9781493946822
856 4 0 $u https://doi.org/10.1007/978-1-4939-1881-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)